Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07756034
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerBlood Cancer UnitedRecruiting
NCT07756034Recruiting
—
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfor...Blood Cancer United
NCT07754682
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell LymphomaAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07754682Not Yet Recruiting
Phase 3
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in...Assistance Publique - Hôp...
NCT07754513
Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastatic Colorectal CancerFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07754513Not Yet Recruiting
—
Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastat...Fondazione Policlinico Un...
NCT07756411
Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Open-angle Glaucoma.University of UdineCompletedNot Applicable
NCT07756411Completed
Not Applicable
Selective, Micropulse and Pattern Laser Trabeculoplasty in Medically Treated Ope...University of Udine
NCT07756385
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs. Centurion)University Hospital Sveti DuhRecruitingNot Applicable
NCT07756385Recruiting
Not Applicable
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs....University Hospital Sveti...
NCT07755917
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile HealthDongying People's HospitalNot Yet RecruitingNot Applicable
NCT07755917Not Yet Recruiting
Not Applicable
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Inte...Dongying People's Hospita...
NCT07755748
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response IncentivesCenters for Disease Control and PreventionNot Yet RecruitingNot Applicable
NCT07755748Not Yet Recruiting
Not Applicable
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Inc...Centers for Disease Contr...
NCT07756281
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic CancerRevolution Medicines, Inc.Not Yet RecruitingPhase 1
NCT07756281Not Yet Recruiting
Phase 1
First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pa...Revolution Medicines, Inc...
NCT07754396
Effect of Tranexamic Acid on Bleeding After Bariatric SurgeryG.Gennimatas General HospitalCompleted
NCT07754396Completed
—
Effect of Tranexamic Acid on Bleeding After Bariatric SurgeryG.Gennimatas General Hosp...
NCT07755462
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibular Syndesmosis With or Without Fixation of the Posterior Fragments in Bimalleolar or Equivalent FracturesGroupe Hospitalier Diaconesses Croix Saint-SimonActive Not RecruitingNot Applicable
NCT07755462Active Not Recruiting
Not Applicable
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibula...Groupe Hospitalier Diacon...
NCT07755644
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07755644Not Yet Recruiting
Not Applicable
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk University
NCT07753993
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.AstraZenecaNot Yet RecruitingPhase 3
NCT07753993Not Yet Recruiting
Phase 3
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult...AstraZeneca
NCT07756255
A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescents With ADHDAlberta Children's HospitalNot Yet RecruitingPhase 2
NCT07756255Not Yet Recruiting
Phase 2
A Clinical Trial Evaluating Fecal Microbiota Transplantation (FMT) in Adolescent...Alberta Children's Hospit...
NCT07754942
Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel OcclusionZhongshan Hospital Xiamen UniversityNot Yet Recruiting
NCT07754942Not Yet Recruiting
—
Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel O...Zhongshan Hospital Xiamen...
NCT07754734
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter MethylationDongguan People's HospitalNot Yet RecruitingPhase 2
NCT07754734Not Yet Recruiting
Phase 2
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With M...Dongguan People's Hospita...
NCT07754435
Neonatal Laparotomy - A Trial Investigating the Impact of Location of SurgeryGuy's and St Thomas' NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07754435Not Yet Recruiting
Not Applicable
Neonatal Laparotomy - A Trial Investigating the Impact of Location of SurgeryGuy's and St Thomas' NHS...
NCT07756060
Creatine Supplementation in Pediatric Brain InjurySpaulding Rehabilitation HospitalNot Yet RecruitingNot Applicable
NCT07756060Not Yet Recruiting
Not Applicable
Creatine Supplementation in Pediatric Brain InjurySpaulding Rehabilitation...
NCT07755956
Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisZhuhai Huahaikang Pharmaceutical Technology Co., Ltd.Not Yet RecruitingPhase 1
NCT07755956Not Yet Recruiting
Phase 1
Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisZhuhai Huahaikang Pharmac...
NCT07754097
Self-Management Data and Disease Progression in Chronic Kidney DiseaseChungnam National University HospitalRecruiting
NCT07754097Recruiting
—
Self-Management Data and Disease Progression in Chronic Kidney DiseaseChungnam National Univers...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 32 (10%)
Phase 12 (10%)
Phase 22 (10%)